Información de la revista
Número
Vol. 30. Núm. 2. (En progreso)(marzo - abril 2025)
Este sumario está en progreso pero sus artículos están finalizados y son citables.
Concise reviews
Surveillance and management of hepatocellular carcinoma after treatment of hepatitis C with direct-acting antiviral drugs
Caiyun Yang, Fengxiang Lv, Jiaqi Yang, Dawei Ding, Lina Cui, Ying Han
Acceso a texto completo
Original articles
Association of sleep patterns and disorders with metabolic dysfunction-associated steatotic liver disease and liver fibrosis in contemporary American adults
Guannan Zong, Wangjia Mao, Ming Wen, Xiaoyun Cheng, Guanghui Liu
Acceso a texto completo
A comprehensive meta-analysis of stem cell therapy for liver failure: Assessing treatment efficacy and modality
Shenglong Lin, Haibing Gao, Huaxi Ma, Ziyuan Liao, Dongqing Zhang, Jinshui Pan, Yueyong Zhu
Acceso a texto completo
Camrelizumab combined with transcatheter arterial chemoembolization and sorafenib or lenvatinib for unresectable hepatocellular carcinoma: A multicenter, retrospective study
Xiumei Jiang, Pan Wang, Ke Su, Han Li, Hao Chi, Fei Wang, Yu Liu, Ke Xu
Acceso a texto completo
Prevalence and risk factors of significant fibrosis in chronic hepatitis B patients with concurrent metabolic dysfunction-associated steatotic liver disease
Shan Hong, Yiwei Hao, Lei Sun, Ping Li, Junru Yang, Fuyang Zhang, Lingling He, Jing Zhang, Hongshan Wei
Acceso a texto completo